Dendreon Shows Provenge Demand, Seattle Genetics Inks Big Deal, Corey Gets Top Hutch Job, & More Seattle-Area Life Sciences News

The biotech world has been dying to know how Dendreon is doing with the market introduction of its groundbreaking prostate cancer drug, and this week we found out. —Dendreon (NASDAQ: [[ticker:DNDN]]) had a big week in the news. Investors were eagerly awaiting the first quarterly report from the Seattle biotech company reflecting actual product sales … Continue reading “Dendreon Shows Provenge Demand, Seattle Genetics Inks Big Deal, Corey Gets Top Hutch Job, & More Seattle-Area Life Sciences News”

iPlaySportz Receives $3,317,241 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=41d2383b-96a2-4fb8-98bc-71e274477491&Preview=1 Date 8/5/2010 Company Name iPlaySportz Mailing Address 7818 78th Ave. SE. Mercer Island, WA 98040 Company Description The company is using web technology to organize and automate youth sports information and registration. Website http://www.korrio.com Transaction Type Venture Equity Transaction Amount $3,317,241 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. … Continue reading “iPlaySportz Receives $3,317,241 New Round”

EE Tech Gets $280K; Army Backing

Empowering Engineering Technologies, the Seattle-based company that seeks to help disabled people walk around better, said today it has secured $280,000 out of a Series A financing round that could be worth as much as $750,000. Part of the investment came from Wings, the medical device angel network supported by the Washington Biotechnology & Biomedical … Continue reading “EE Tech Gets $280K; Army Backing”

Zulily, Off to Fast Start in Private Sale E-Commerce, Raises $6M More from August Capital, Maveron

Seattle-based private-sales company Zulily is announcing today it has closed $6 million in Series B financing led by August Capital, along with existing investor Seattle-based Maveron. The website, which went live on January 27, rolled out of stealth back in December with the support of an initial $4.6 million round. Six short months later, co-founder … Continue reading “Zulily, Off to Fast Start in Private Sale E-Commerce, Raises $6M More from August Capital, Maveron”

Zulily Obtains $6,000,000 Series B Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=25bcda7d-4836-40f2-92df-df06554139c0&Preview=1 Date 8/4/2010 Company Name Zulily Mailing Address 505 5th Avenue South Seattle, WA 98104 Company Description Just what is zulily? It’s a fabulous new online store offering daily sales on top-quality apparel, gear and other goodies for moms, babies and kids. Members can enjoy savings of up to 70% off retail … Continue reading “Zulily Obtains $6,000,000 Series B Funding Round”

Dendreon Conference Call Notebook: The Tale of a Provenge Launch Ramp-Up

Dendreon’s drug isn’t as simple as a pill in a bottle, and neither is telling the story about how it performs in the marketplace. But the Seattle-based biotech company offered a lot of information in a conference call today about how its groundbreaking prostate cancer drug is performing in its first few months on the … Continue reading “Dendreon Conference Call Notebook: The Tale of a Provenge Launch Ramp-Up”

Dendreon Misses Wall Street’s (Already Low) Expectations for Provenge Sales

Dendreon, in its first two months on the market, sold a lot less of its groundbreaking drug for prostate cancer than analysts were expecting. The Seattle-based biotech company (NASDAQ: [[ticker:DNDN]]) said it generated $2.81 million in sales of its first FDA-approved product, sipuleucel-T (Provenge) for prostate cancer. That’s less than the $4.4 million average estimate … Continue reading “Dendreon Misses Wall Street’s (Already Low) Expectations for Provenge Sales”

Genentech Agrees to Pay Seattle Genetics Up to $900M for “Empowered Antibodies”

Genentech and Seattle Genetics have been working together for eight years on how to make antibody drugs that can really firebomb cancer cells, and today they are raising the ante in a big way. Seattle Genetics (NASDAQ: [[ticker:SGEN]]) said today that Genentech, the U.S.-based unit of Roche, has agreed to pay $12 million in upfront … Continue reading “Genentech Agrees to Pay Seattle Genetics Up to $900M for “Empowered Antibodies””

Seattle’s Growing Advantage in The Cloud

Cloud computing and biotech are the two most important nonlinearly-growing economic sectors. These two sectors intersect in Seattle in a unique way that has important implications for all involved. Small changes now will make big changes in what our lives are like decades from today, and Seattleites will have a ringside seat. For now, there … Continue reading “Seattle’s Growing Advantage in The Cloud”

Dendreon Watchers: Buckle Up for Action in First Quarterly Report With Actual Sales

Dendreon followers, it’s time to get ready for another spin on the great NASDAQ merry-go-round later today. The Seattle-based biotech firm (NASDAQ: [[ticker:DNDN]]), a poster child for wild and sometimes irrational stock market swings, is preparing to release its first quarterly report this afternoon as a company with actual sales from a product. Whatever Dendreon … Continue reading “Dendreon Watchers: Buckle Up for Action in First Quarterly Report With Actual Sales”

Daptiv Acquired, DocuSign Inks Partnership, Healthcare and Energy Companies Bring in the Most Dough, & More Seattle-Area Deals News

It’s been a relatively slow week for Seattle-area technology deals (sunny weather strikes again!). Only one local tech startup reported financing over this last week, while, much like the week before, two others were acquired, this time both by big companies down south.. Take a look at this week’s highlights: —Seattle-based project management software developer … Continue reading “Daptiv Acquired, DocuSign Inks Partnership, Healthcare and Energy Companies Bring in the Most Dough, & More Seattle-Area Deals News”

The Embargo System in Science News Needs Some Peer Review

Ever wonder how it is that the day a big scientific paper is published, or a groundbreaking presentation is given at a meeting, all major media outlets seem to have the story right away? It doesn’t happen by chance. The massive coordination effort is known as the embargo system. It is one of the most … Continue reading “The Embargo System in Science News Needs Some Peer Review”

Seattle Geek Week

Join countless other local techies at Seattle’s inaugural Geek Week, August 13th to 22nd, for ten days of “geeky” conferences, workshops, meetups, and parties. (Check out the schedule here.) All events are independently produced and will be put on at various locations throughout Seattle, Bellevue, and Redmond. For more information, click here.

The Intuit Case Study: Connecting the Dots Between Social Media and Business Outcomes

Join Kira Wampler, former group marketing manager of online engagement at Intuit, on August 10th at RealNetworks for a discussion about one of the biggest challenges for businesses using social media: making the connection between social activity and actual business performance. The event is being hosted by Social Media Breakfast Seattle. Those who can’t make … Continue reading “The Intuit Case Study: Connecting the Dots Between Social Media and Business Outcomes”

Delve Networks Acquired By Limelight

Delve Networks, the Seattle-based online video hosting and “search inside” video technology startup, said today it has been acquired by Tempe, AZ-based Limelight Networks (NASDAQ: [[ticker:LLNW]]). Though financial terms of the deal were not disclosed, blogger Dan Rayburn, at Businessofvideo.com, reported the deal valued Delve at about $10 million. Delve, founded in 2006 (then known … Continue reading “Delve Networks Acquired By Limelight”

Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch

Raising her son in a middle class home in the Detroit area in the ’50s and ’60s, Larry Corey‘s mother dreamed he’d become a doctor. Now he’s set his sights much higher, as the new president and director of one of the world’s leading biomedical research institutes, a place that seeks to do no less … Continue reading “Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch”

With Traditional M&A Players Still on Sidelines, Small and Mid-sized Businesses Have Unique Opportunity to Make Strategic Acquisitions

The recent economic turmoil forced rapid change on the mergers and acquisitions marketplace, as the tightening of available credit pushed traditional M&A players—primarily private equity investors and large corporations—to the sidelines and dramatically slowed existing transactions. The landscape yielded a dearth of profitable deals, with any residual motivation for investment in mid-sized firms deflated by … Continue reading “With Traditional M&A Players Still on Sidelines, Small and Mid-sized Businesses Have Unique Opportunity to Make Strategic Acquisitions”

iTunes Meets Facebook & Epicurious: Kitchen Monki Brings A Number of Big Internet Ideas To the World of Food

There’s no denying Seattle is a tech savvy town. And when it comes to food, I think it’s safe to say we’re climbing up in the ranks. We’re the most caffeinated city in the country, according to The Daily Beast (no surprise there), and when it comes to the intersection of food and tech, we … Continue reading “iTunes Meets Facebook & Epicurious: Kitchen Monki Brings A Number of Big Internet Ideas To the World of Food”

Limelight Networks Acquires Delve Networks for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8ae13576-d3e9-4f1b-87ce-e5c1287ecb1b&Preview=1 Date 8/2/2010 Company Name Delve Networks Mailing Address 1008 Western Ave Seattle, WA 98104 Company Description Thanks to the growth of broadband combined with on-demand access to vast content libraries, audiences worldwide are embracing online video viewing and content providers are using the power of the Internet to distribute media. A … Continue reading “Limelight Networks Acquires Delve Networks for Undisclosed Sum”

Hutch Names Larry Corey as New President, To Build on Hartwell’s Growth Legacy

The Fred Hutchinson Cancer Research Center, one of the world’s leading centers for biomedical research and innovation, has found its new leader after a year of searching. Larry Corey, the international HIV vaccine expert, has been named to replace the retiring Nobel laureate Lee Hartwell, 70, in the top job at the Seattle-based nonprofit research … Continue reading “Hutch Names Larry Corey as New President, To Build on Hartwell’s Growth Legacy”

OpenAppMkt: The Return of the iPhone Web App?

Few people remember it now, but for the first year after the launch of the Apple iPhone in June, 2007, there was no App Store. The device came with a few built-in or “native” apps like a calendar, a clock, and a notebook, along with a couple of third-party apps like the YouTube player and … Continue reading “OpenAppMkt: The Return of the iPhone Web App?”

Gates Foundation’s Tachi Yamada: Biotechies and VCs are Missing Out on Global Health

Tachi Yamada was a big name in Big Pharma before he took the top global health job at the world’s richest charitable organization, the Bill & Melinda Gates Foundation. But no single organization—not even a multi-national, multi-billion dollar R&D shop at GlaxoSmithKline, or the Gates Foundation—can conquer leading killers like HIV, tuberculosis, diarrheal diseases, and … Continue reading “Gates Foundation’s Tachi Yamada: Biotechies and VCs are Missing Out on Global Health”

Total Living Choices Garners $2,200,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e974364-81d3-43d2-897a-6abd04176f5e&Preview=1 Date 7/30/2010 Company Name Total Living Choices Mailing Address 1633 Westlake Ave. N. Seattle, WA 98109 Company Description Total Living Choices is a leading healthcare technology Company dedicated to assisting hospitals, families, and post-acute providers during patient transition. Website http://www.twilightliving.com Transaction Type Venture Equity Transaction Amount $2,200,000 Transaction Round Undisclosed Proceeds … Continue reading “Total Living Choices Garners $2,200,000 New Round”

Total Living Choices Nabs $2.2M

Seattle-based online senior care information and referral service Total Living Choices (also known as TwilightLiving) has raised $2.2 million in equity out of a $3.5 million offering, according to a regulatory filing. The company, founded in 1999, maintains a database of over 68,000 nursing homes, assisted living facilities, home care, hospice, medical equipment, and long-term … Continue reading “Total Living Choices Nabs $2.2M”

Fierce Competition at the TechFlash Summer BBQ & Ping-Pong Tournament

There was some serious action going on last night at TechFlash’s second annual Summer BBQ and Ping-Pong Tournament. With over 400 in attendance, techies from far and wide traded in their smartphones for paddles, and battled it out for the championship.

For the less athletically inclined, there was also the first ever foosball competition, and an award for the team with the most spirit (i.e. the zaniest costumes…I mean uniforms), which went to social media agency Banyan Branch, whose mascot could only be described as ‘shaggy.’ (See pictures here).

Early Theraclone Scientist Lee Adams Dies in Mount Rainier Climbing Accident

Some more sad news has hit the Seattle biotech community. Lee Adams, one of the early employees at Spaltudaq, now Theraclone Sciences, died this week on Mount Rainier after a fall into a crevasse. He was 52. The Seattle Times has a solid story on what happened on the mountain at 13,000 feet of elevation. … Continue reading “Early Theraclone Scientist Lee Adams Dies in Mount Rainier Climbing Accident”

The Northwest Tech Scene, Public Policy, and Collaboration: WTIA CEO Susan Sigl on Her First 100 Days & What’s In Store

Three months have flown by since Susan Sigl succeeded Ken Myer as the CEO of the Washington Technology Industry Association (WTIA). The 26-year-old organization is the largest statewide association of tech companies and executives in the world, representing some 1,100 members and 125,000 tech employees across Washington, with a staff of just 11. That’s quite … Continue reading “The Northwest Tech Scene, Public Policy, and Collaboration: WTIA CEO Susan Sigl on Her First 100 Days & What’s In Store”

Immune Design Pockets $32M, InDi Nails $10M, SonoSite Looks Inside My Carotids, & More Seattle-Area Life Sciences News

This week, we saw more than the usual number of venture deals on the Seattle life sciences beat. Maybe the VCs needed to tie up some loose ends before unplugging in the month of August. —Seattle-based Immune Design snagged the big round of the week, a full $32 million Series B deal that included ProQuest … Continue reading “Immune Design Pockets $32M, InDi Nails $10M, SonoSite Looks Inside My Carotids, & More Seattle-Area Life Sciences News”

Dendreon Gets Published in NEJM

Dendreon (NASDAQ: [[ticker:DNDN]]), the Seattle-based developer of immune-boosting therapies for cancer, said today that the New England Journal of Medicine has published results from the study of 512 men with prostate cancer that led to the FDA approval of sipuleucel-T (Provenge). The study showed Provenge could extend lifespan with minimal side effects back in April … Continue reading “Dendreon Gets Published in NEJM”

Marina Gets RNAi Delivery Tools for $5M

Marina Biotech (NASDAQ: [[ticker:MRNAD]]), the Bothell, WA-based company formerly known as MDRNA, has acquired intellectual property rights to a variety of RNA interference drug delivery technologies from Germany-based Novosom. Marina agreed to provide $5 million worth of its common stock in exchange for rights to use Novosom’s liposomal-particle delivery system that’s supposed to get RNA-silencing … Continue reading “Marina Gets RNAi Delivery Tools for $5M”

Protecting Consumers From Their Own Genetic Data Will Come at a Cost

Last week’s U.S. House Energy and Commerce Committee hearing into the direct-to-consumer (DTC) genetic testing industry was a vicious affair, with more than a whiff of the show trial about it. Representatives from testing companies 23andMe, Navigenics and Pathway Genomics faced a barrage of questions about the accuracy and utility of their tests, made all … Continue reading “Protecting Consumers From Their Own Genetic Data Will Come at a Cost”

DocuSign Partners with MeridianLink

Seattle-based electronic signature automation software developer DocuSign said today it has joined in a partnership with web-based financial software company MeridianLink, out of Costa Mesa, CA. Through the deal MeridianLink, which offers online loan origination and account opening applications for consumers, will integrate DocuSign electronic signature capabilities into its existing system. DocuSign said the partnership … Continue reading “DocuSign Partners with MeridianLink”

HemaQuest Raises $4M More, Boosting VC Round to $16M for Sickle Cell, Blood Disorders

Another few months have gone by, and another few million bucks have arrived in the corporate treasury for HemaQuest Pharmaceuticals. The Seattle-based developer is announcing today it has raised $4 million for its experimental treatments for sickle cell anemia and other blood disorders. The financing comes from a new investor, Latterell Venture Partners. This latest … Continue reading “HemaQuest Raises $4M More, Boosting VC Round to $16M for Sickle Cell, Blood Disorders”

Washington Startups Pull In $104.3M in June; Healthcare and Energy/Utilities Sectors Top the List

Compared to the handful of “under the radar” deals we had to report on in our May roundup, the month of June was buzzing with deals, both small and large, for Seattle-area tech and biotech companies. Normally we publish our “under the radar” roundup for regional deals worth less than $1 million in a monthly … Continue reading “Washington Startups Pull In $104.3M in June; Healthcare and Energy/Utilities Sectors Top the List”

HemaQuest Pharmaceuticals Receives $4,000,000 Series B Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=37c0f677-bbd5-4a15-be27-f940911161d4&Preview=1 Date 7/28/2010 Company Name HemaQuest Pharmaceuticals Mailing Address 1229 Madison Street Seattle, WA 98104 Company Description HemaQuest is a company developing proprietary small molecule therapeutics to treat serious blood disorders. Website http://www.hemaquest.com Transaction Type Venture Equity Transaction Amount $4,000,000 Transaction Round Series B Proceeds Purposes The financing will be used to … Continue reading “HemaQuest Pharmaceuticals Receives $4,000,000 Series B Round”

Dashwire Garners $515,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8b4408e0-a8ff-4d5a-bc99-8b75669160c3&Preview=1 Date 7/28/2010 Company Name Dashwire Mailing Address 936 N. 34th Street Seattle, WA 98103 Company Description Dashwire seamlessly integrates your mobile phone and the world it captures with your computer and the web, helping you access and share your mobile experiences – no cables required. Website http://www.dashwire.com Transaction Type Venture Equity … Continue reading “Dashwire Garners $515,000 New Financing”

Tableau Doubles Revenue by Making Data More Visual, More Fun

Tableau Software has made it clear over the past year that it is one of the rising stars of the local software community. Spun out from Stanford University in 2003, the company has spent the last seven years carving out a global market of businesspeople and consumers itching for a new product to help them … Continue reading “Tableau Doubles Revenue by Making Data More Visual, More Fun”

Elemental Talks About Its $7.5M Series B, and Cashing In on the New Economics of Online Video

The online video market just got a little hotter. Last month, my colleague Luke broke the news that Elemental Technologies, a parallel-processing video software startup in Portland, OR, had raised a new financing round. Today the company is talking for the first time about the deal and where it stands in an increasingly competitive—and lucrative—market. … Continue reading “Elemental Talks About Its $7.5M Series B, and Cashing In on the New Economics of Online Video”

Immune Design Follows Corixa Playbook, Sees Data, Deals on the Horizon in Year Three

Steve Reed is following a tried-and-true road map for building a biotech company. First year, build the team. Second year, gather some data to support the founding idea. Third year, prove it in clinical trials. Then start coaxing Big Pharma to open up its checkbook and do deals. “This is when it gets exciting,” Reed … Continue reading “Immune Design Follows Corixa Playbook, Sees Data, Deals on the Horizon in Year Three”

Daptiv Acquired By Parallax Capital Partners

Seattle-based project management software developer Daptiv is confirming today it has been acquired by software and technical acquisition firm Parallax Capital Partners, out of Laguna Hills, CA. The official announcement came this morning, after a report about the deal leaked late last week. Daptiv, founded in 1997, develops on-demand collaborative business and project and portfolio … Continue reading “Daptiv Acquired By Parallax Capital Partners”

Jive Software Nabs $30M, SynapticMash Acquired by Promethean World, Intellectual Ventures Sells Patents, & More Seattle-Area Deals News

Once again it has been a pretty slow week for Seattle-area technology companies in terms of deals—word must have gotten out that the weather is nice and warm here in the Pacific Northwest! Nevertheless, of the few deals that have gone on this last week, a few were pretty substantial. A number of startups both … Continue reading “Jive Software Nabs $30M, SynapticMash Acquired by Promethean World, Intellectual Ventures Sells Patents, & More Seattle-Area Deals News”

Elemental Technologies Garners $7,500,000 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9a55e112-e046-475f-8dbb-a501f0c39ca5&Preview=1 Date 7/27/2010 Company Name Elemental Technologies Mailing Address 620 SW Fifth Ave. Portland, OR 97204 Company Description Elemental Technologies, headquartered in Portland, Oregon, is the leading provider of massively parallel processing (MPP) solutions, initially targeting video applications. Utilizing general purpose, programmable “off the shelf” graphics processing units (GPUs), the RapiHD™ Video … Continue reading “Elemental Technologies Garners $7,500,000 Series B Financing”

Gist Raises $4M More from Vulcan and Foundry Group

Seattle-based software startup Gist has raised an additional $4 million in equity financing, according to VentureDeal. Gist vice president of marketing Robert Pease confirmed the deal, adding that the latest round came from existing investors, Paul Allen’s Vulcan Capital and Boulder, Co-based firm Foundry Group. Gist develops online software that helps business people keep track … Continue reading “Gist Raises $4M More from Vulcan and Foundry Group”

Washington to Washington: A Shared Vision for Global Health

Top state, federal, and global health officials are gathering at PATH’s new Seattle headquarters on July 29th for a public conversation in the midst of budget debates about global health and foreign aid priorities. Washington Gov. Chris Gregoire is one of the confirmed speakers, along with Tachi Yamada, the president of global health at the … Continue reading “Washington to Washington: A Shared Vision for Global Health”

Immune Design Nabs $32M for Targeted Vaccines

Seattle-based Immune Design has raised $32 million to develop a new generation of vaccines. It’s the second big round for the company, founded in 2008 with an $18 million investment. The latest financing was led by ProQuest Investments, and included Immune Design’s previous investors—The Column Group, Versant Ventures, and Alta Partners. The new investment is … Continue reading “Immune Design Nabs $32M for Targeted Vaccines”

Vlingo Buys Patents from Bellevue-based Intellectual Ventures As Defense In Nuance Lawsuit—Hopes for “Horse Trade”

Vlingo, a Cambridge, MA-based provider of voice-to-text software, has taken a defensive move to help protect it against a lawsuit filed by speech software giant Nuance Communications, announcing a deal today with Intellectual Ventures that adds a slew of intellectual property to its arsenal. Vlingo has purchased several patents from Bellevue, WA-based Intellectual Ventures that … Continue reading “Vlingo Buys Patents from Bellevue-based Intellectual Ventures As Defense In Nuance Lawsuit—Hopes for “Horse Trade””